首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Conservative care in Europe - Nephrologists' experience with the decision not to start renal replacement therapy
【24h】

Conservative care in Europe - Nephrologists' experience with the decision not to start renal replacement therapy

机译:欧洲的保守治疗-肾脏科医生决定不开始肾脏替代治疗的经验

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BackgroundFor some patients with end-stage renal disease (ESRD), providing conservative care until death may be an acceptable alternative for renal replacement therapy (RRT). We aimed to estimate the occurrence of conservative care in Europe and evaluated opinions about which factors nephrologists consider important in their decision not to offer RRT.MethodsWith a web-based survey sent to nephrologists in 11 European countries, we inquired how often RRT was not started in 2009 and how specific factors would influence the nephrologists' decision to provide conservative care. We compared subgroups by nephrologist and facility characteristics using chi-square tests and Mann-Whitney U tests.ResultsWe received 433 responses. Nephrologists decided to offer conservative care in 10% of their patients [interquartile range (IQR) 5-20%]. An additional 5% (IQR 2-10%) of the patients chose conservative care as they refused when nephrologists intended to start RRT. Patient preference (93%), severe clinical conditions (93%), vascular dementia (84%) and low physical functional status (75%) were considered extremely or quite important in the nephrologists' decision to provide conservative care. Nephrologists from countries with a low incidence of RRT, not-for-profit centres and public centres more often scored these factors as extremely or quite important than their counterparts from high-incidence countries, for-profit centres and private centres.ConclusionsNephrologists estimated conservative care was provided to up to 15% of their patients in 2009. The presence of severe clinical conditions, vascular dementia and a low physical functional status are important factors in the decision-making not to start RRT. Patient preference was considered as a very important factor, confirming the importance of extensive patient education and shared decision-making.
机译:背景对于一些患有终末期肾脏疾病(ESRD)的患者,提供保守治疗直至死亡可能是肾脏替代疗法(RRT)的可接受替代方案。我们的目的是评估欧洲保守治疗的发生率,并评估关于肾病医师决定不提供RRT的哪些因素的观点。方法通过向11个欧洲国家的肾脏病专家发送基于网络的调查,我们询问了RRT停用的频率以及2009年的具体因素如何影响肾脏科医生提供保守治疗的决定。我们使用卡方检验和Mann-Whitney U检验按肾病专家和设施特征对亚组进行了比较。结果我们收到433份答复。肾病学家决定为10%的患者提供保守治疗[四分位间距(IQR)5-20%]。另有5%(IQR 2-10%)的患者选择了保守治疗,因为当肾脏科医生打算开始RRT时他们拒绝了。在肾病医生提供保守治疗的决定中,患者的偏爱(93%),严重的临床状况(93%),血管性痴呆(84%)和低的身体机能状态(75%)被认为极为重要。来自RRT发生率较低的国家,非营利中心和公共中心的肾病医生比来自高发病率国家,营利中心和私人中心的肾病患者更经常将这些因素评为极为重要或相当重要。 2009年,他们为多达15%的患者提供了该药物。严重的临床状况,血管性痴呆和较低的身体机能状态是决定不启动RRT的重要因素。患者的偏爱被认为是一个非常重要的因素,证实了广泛的患者教育和共同决策的重要性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号